Skip to content

Establishment and application of Clinical Pathway for Ehanced Recovery After Suegery in gynecological laparoscopic surgery.

Establishment and application of Clinical Pathway for Ehanced Recovery After Suegery in gynecological laparoscopic surgery.

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043645
Enrollment
Unknown
Registered
2021-02-24
Start date
2020-10-01
Completion date
Unknown
Last updated
2021-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign gynecologic diseases and early malignant tumors to be treated with laparoscopic surgery

Interventions

ERAS Group:ERAS measure
Control Group:traditional measure

Sponsors

Peking University International Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: The patients with benign gynecologic diseases and early malignant tumors who plan to undergo gynecologic laparoscopic surgery are those with clinical stage I-II endometrial cancer, IA-IIA cervical cancer, and I-II ovarian cancer.

Exclusion criteria

Exclusion criteria: Aged >= 65 years, diabetic patients, patients with gastroesophageal reflux, patients with severe organ dysfunction, previous history of intestinal obstruction or intestinal surgery, pelvic abscess, deep endometriosis and other suspected severe pelvic adhesion, and patients with stage III and IV endometrial cancer, cervical cancer and ovarian cancer.

Design outcomes

Primary

MeasureTime frame
length of stay;

Secondary

MeasureTime frame
readmission rate;postoperative exhaust time;pain score;postoperative ileus rate;postoperative infection rate;postoperative urinary retention rate;postoperative nausea and vomiting rate;albumin;total protein;blood glucose;cortisol;IL-6;white blood cell count;hospitalization expenses;the satisfaction of patients;

Countries

China

Contacts

Public ContactYongjun Wang

Peking University International Hospital

wyongjunhys@sina.com+86 18701131517

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026